Home / Generics

Generics

News

Patent challenges hit Actavis and Acorda posted 28/04/2017

Teva Pharmaceuticals’ subsidiary Actavis and neurological drug specialist Acorda Therapeutics have both faced patent challeng...

FDA approves Akorn’s mycophenolate mofetil following Form 483 resolution posted 07/04/2017

US-based generic pharmaceutical manufacturer, Akorn Inc has announced that its sterile manufacturing site in Decatur, Illinoi...

Generic antidepressant launched in the US posted 31/03/2017

US pharma giant Pfizer is facing competition for its antidepressant Pristiq (desvenlafaxine) with generics hitting the market...

FDA approves rare disease deflazacort at exorbitant price posted 17/03/2017

Deflazacort is a steroid treatment that has long been approved in many countries outside the US. In February 2016, the US Foo...

Generic lung cancer treatment now available in China posted 10/03/2017

A generic version of AstraZeneca’s Iressa (gefitinib) has been released onto the market in China. This generic drug is being...

 

Research

Approaches to assure quality and improve patient perceptions of generics in Japan posted 28/04/2017

The rapidly ageing population in Japan has led the government to promote the use of generics in the universal health insuranc...

Significant price reductions possible for new cancer drugs posted 21/04/2017

Generic production could drastically reduce the prices of novel cancer drugs and make treatments accessible to thousands more...

Generics could cut costs of cancer drugs by over 99% posted 21/04/2017

Generics manufacturing and import of novel cancer drugs could massively reduce their costs in the UK, according to a study by...

Evolution of scientific research on generic drugs posted 21/04/2017

A review of peer-reviewed scientific articles carried out in January 2013 on generic drugs published on PubMed/MEDLINE from t...

Potency of generics of piperacillin/tazobactam posted 21/04/2017

In an era of increasing bacterial resistance, the potency of antibiotics is critical. Researchers from the Tata Medical Centr...

 

General

Indian drug industry faces setbacks in Europe and the US posted 28/04/2017

The European Medicines Agency (EMA) has announced that they have recommended the suspension of generic drug approvals and dru...

FDA commits to success of the generic and biosimilar second-generation user fee acts posted 21/04/2017

Representatives of the Centre for Drug Evaluation and Research (CDER), the Association of Accessible Medicines (AAM), the Bio...

Malaysian Government approves new generics facility posted 09/03/2017

Bangladesh-based generics firm Beximco Pharmaceuticals (Beximco) has made a deal with Malaysia’s BioCare Manufacturing (BioCa...

Novo Nordisk becomes second pharma company to cap price hikes posted 01/03/2017

Danish pharmaceutical company Novo Nordisk has pledged to limit the price rises of their drugs to single digit increases each...

Generics regulators outline priorities to 2020 posted 31/01/2017

The International Generic Drug Regulatory Programme (IGDRP) announced on 21 December 2016 that it had released its ‘Road...

Generics News Research General

more

Biosimilars News Research General

more